Intralesional Cryotherapy for Treatment of Keloid Scars: A Prospective Study

Intralesional cryotherapy is a novel treatment for keloid scars in which the scar is frozen from inside. Published results are promising, but the treatment has only been tested in a Caucasian patient population. Therefore, the authors evaluated intralesional cryotherapy in a patient population inclu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Plastic and reconstructive surgery (1963) 2015-02, Vol.135 (2), p.580-589
Hauptverfasser: van Leeuwen, Michiel C. E., van der Wal, Martijn B. A., Bulstra, Anne-Eva J., Galindo-Garre, Francisca, Molier, Jonneke, van Zuijlen, Paul P. M., van Leeuwen, Paul A. M., Niessen, Frank B.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 589
container_issue 2
container_start_page 580
container_title Plastic and reconstructive surgery (1963)
container_volume 135
creator van Leeuwen, Michiel C. E.
van der Wal, Martijn B. A.
Bulstra, Anne-Eva J.
Galindo-Garre, Francisca
Molier, Jonneke
van Zuijlen, Paul P. M.
van Leeuwen, Paul A. M.
Niessen, Frank B.
description Intralesional cryotherapy is a novel treatment for keloid scars in which the scar is frozen from inside. Published results are promising, but the treatment has only been tested in a Caucasian patient population. Therefore, the authors evaluated intralesional cryotherapy in a patient population including different Fitzpatrick skin types (I through VI). This prospective multicenter study with a 1-year follow-up included 27 patients with 29 keloid scars. Intralesional cryotherapy was administered with a disposable liquid nitrogen-based device called CryoShape. Scar assessment was performed using the Patient and Observer Scar Assessment Scale and four objective devices to determine scar color, scar elasticity, scar volume, and patient skin type. Keloid scars showed an average volume decrease of 63 percent (range, 16 to 100 percent) after 12 months, compared with baseline (p < 0.01). Recurrence was seen in seven keloids (24 percent) and hypopigmentation recovered in 69 percent of all keloid scars within 12 months. Scar assessment with the Patient and Observer Scar Assessment Scale showed an overall improvement according to both doctors and patients. In addition, complaints of pain and itching were reduced. When analyzing the results per Fitzpatrick skin type, African American patients showed a higher incidence of persistent hypopigmentation (p = 0.02). Intralesional cryotherapy for the treatment of keloid scars shows favorable results in terms of reduction of volume and complaints of pain and pruritus. However, no complete eradication was obtained in some cases and recurring scars were seen. In addition, persistent hypopigmentation proved a problem in non-Caucasian patients. Therapeutic, IV.
doi_str_mv 10.1097/PRS.0000000000000911
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1652418328</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1652418328</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3016-6615c88b9a6cb561eed18cc0cca8de764bce7a093db7d9b6cd8041429590f1eb3</originalsourceid><addsrcrecordid>eNpdkFtLJDEQhYO46Oj6D0Ty6Eu7Vekk3e2bDN7YgZUdfW7S6WqmNTMZk7Qy_972vmxBURScc6r4GDtEOEGoil83f-cn8G9ViFtsgkpUmRRSbLMJQC4yBCV22V6M9wBY5FrtsF2htNAl4ITNrlcpGEex9yvj-DRsfFpQMOsN73zgt4FMWtIqcd_x3-R83_K5NSGe8jN-E3xck039E_F5GtrNT_ajMy7SwcfcZ3cX57fTq2z25_J6ejbLbA6oM61R2bJsKqNtozQStVhaC9aasqVCy8ZSYaDK26Zoq0bbtgSJUlSqgg6pyffZ8XvuOvjHgWKql3205JxZkR9ijVoJiWUuylEq36V2fDYG6up16JcmbGqE-pVjPXKs_-c42o4-LgzNktov0ye479xn7xKF-OCGZwr1goxLi7c8rXKZCUAFYtyysaXOXwDobn1f</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1652418328</pqid></control><display><type>article</type><title>Intralesional Cryotherapy for Treatment of Keloid Scars: A Prospective Study</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>van Leeuwen, Michiel C. E. ; van der Wal, Martijn B. A. ; Bulstra, Anne-Eva J. ; Galindo-Garre, Francisca ; Molier, Jonneke ; van Zuijlen, Paul P. M. ; van Leeuwen, Paul A. M. ; Niessen, Frank B.</creator><creatorcontrib>van Leeuwen, Michiel C. E. ; van der Wal, Martijn B. A. ; Bulstra, Anne-Eva J. ; Galindo-Garre, Francisca ; Molier, Jonneke ; van Zuijlen, Paul P. M. ; van Leeuwen, Paul A. M. ; Niessen, Frank B.</creatorcontrib><description>Intralesional cryotherapy is a novel treatment for keloid scars in which the scar is frozen from inside. Published results are promising, but the treatment has only been tested in a Caucasian patient population. Therefore, the authors evaluated intralesional cryotherapy in a patient population including different Fitzpatrick skin types (I through VI). This prospective multicenter study with a 1-year follow-up included 27 patients with 29 keloid scars. Intralesional cryotherapy was administered with a disposable liquid nitrogen-based device called CryoShape. Scar assessment was performed using the Patient and Observer Scar Assessment Scale and four objective devices to determine scar color, scar elasticity, scar volume, and patient skin type. Keloid scars showed an average volume decrease of 63 percent (range, 16 to 100 percent) after 12 months, compared with baseline (p &lt; 0.01). Recurrence was seen in seven keloids (24 percent) and hypopigmentation recovered in 69 percent of all keloid scars within 12 months. Scar assessment with the Patient and Observer Scar Assessment Scale showed an overall improvement according to both doctors and patients. In addition, complaints of pain and itching were reduced. When analyzing the results per Fitzpatrick skin type, African American patients showed a higher incidence of persistent hypopigmentation (p = 0.02). Intralesional cryotherapy for the treatment of keloid scars shows favorable results in terms of reduction of volume and complaints of pain and pruritus. However, no complete eradication was obtained in some cases and recurring scars were seen. In addition, persistent hypopigmentation proved a problem in non-Caucasian patients. Therapeutic, IV.</description><identifier>ISSN: 0032-1052</identifier><identifier>ISSN: 1529-4242</identifier><identifier>EISSN: 1529-4242</identifier><identifier>DOI: 10.1097/PRS.0000000000000911</identifier><identifier>PMID: 25626801</identifier><language>eng</language><publisher>United States: American Society of Plastic Surgeons</publisher><subject>Adolescent ; Adult ; Aged ; Asian People ; Black or African American ; Black People ; Child ; Cryosurgery - adverse effects ; Cryosurgery - instrumentation ; Cryosurgery - methods ; Female ; Humans ; Hypopigmentation - etiology ; Injections, Intralesional ; Keloid - complications ; Keloid - therapy ; Male ; Middle Aged ; Needles ; Netherlands ; Nitrogen - administration &amp; dosage ; Nitrogen - therapeutic use ; Pain - etiology ; Postoperative Complications - etiology ; Prospective Studies ; Pruritus - etiology ; Recurrence ; Severity of Illness Index ; Skin Pigmentation ; White People ; Young Adult</subject><ispartof>Plastic and reconstructive surgery (1963), 2015-02, Vol.135 (2), p.580-589</ispartof><rights>American Society of Plastic Surgeons</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3016-6615c88b9a6cb561eed18cc0cca8de764bce7a093db7d9b6cd8041429590f1eb3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25626801$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>van Leeuwen, Michiel C. E.</creatorcontrib><creatorcontrib>van der Wal, Martijn B. A.</creatorcontrib><creatorcontrib>Bulstra, Anne-Eva J.</creatorcontrib><creatorcontrib>Galindo-Garre, Francisca</creatorcontrib><creatorcontrib>Molier, Jonneke</creatorcontrib><creatorcontrib>van Zuijlen, Paul P. M.</creatorcontrib><creatorcontrib>van Leeuwen, Paul A. M.</creatorcontrib><creatorcontrib>Niessen, Frank B.</creatorcontrib><title>Intralesional Cryotherapy for Treatment of Keloid Scars: A Prospective Study</title><title>Plastic and reconstructive surgery (1963)</title><addtitle>Plast Reconstr Surg</addtitle><description>Intralesional cryotherapy is a novel treatment for keloid scars in which the scar is frozen from inside. Published results are promising, but the treatment has only been tested in a Caucasian patient population. Therefore, the authors evaluated intralesional cryotherapy in a patient population including different Fitzpatrick skin types (I through VI). This prospective multicenter study with a 1-year follow-up included 27 patients with 29 keloid scars. Intralesional cryotherapy was administered with a disposable liquid nitrogen-based device called CryoShape. Scar assessment was performed using the Patient and Observer Scar Assessment Scale and four objective devices to determine scar color, scar elasticity, scar volume, and patient skin type. Keloid scars showed an average volume decrease of 63 percent (range, 16 to 100 percent) after 12 months, compared with baseline (p &lt; 0.01). Recurrence was seen in seven keloids (24 percent) and hypopigmentation recovered in 69 percent of all keloid scars within 12 months. Scar assessment with the Patient and Observer Scar Assessment Scale showed an overall improvement according to both doctors and patients. In addition, complaints of pain and itching were reduced. When analyzing the results per Fitzpatrick skin type, African American patients showed a higher incidence of persistent hypopigmentation (p = 0.02). Intralesional cryotherapy for the treatment of keloid scars shows favorable results in terms of reduction of volume and complaints of pain and pruritus. However, no complete eradication was obtained in some cases and recurring scars were seen. In addition, persistent hypopigmentation proved a problem in non-Caucasian patients. Therapeutic, IV.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Asian People</subject><subject>Black or African American</subject><subject>Black People</subject><subject>Child</subject><subject>Cryosurgery - adverse effects</subject><subject>Cryosurgery - instrumentation</subject><subject>Cryosurgery - methods</subject><subject>Female</subject><subject>Humans</subject><subject>Hypopigmentation - etiology</subject><subject>Injections, Intralesional</subject><subject>Keloid - complications</subject><subject>Keloid - therapy</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Needles</subject><subject>Netherlands</subject><subject>Nitrogen - administration &amp; dosage</subject><subject>Nitrogen - therapeutic use</subject><subject>Pain - etiology</subject><subject>Postoperative Complications - etiology</subject><subject>Prospective Studies</subject><subject>Pruritus - etiology</subject><subject>Recurrence</subject><subject>Severity of Illness Index</subject><subject>Skin Pigmentation</subject><subject>White People</subject><subject>Young Adult</subject><issn>0032-1052</issn><issn>1529-4242</issn><issn>1529-4242</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkFtLJDEQhYO46Oj6D0Ty6Eu7Vekk3e2bDN7YgZUdfW7S6WqmNTMZk7Qy_972vmxBURScc6r4GDtEOEGoil83f-cn8G9ViFtsgkpUmRRSbLMJQC4yBCV22V6M9wBY5FrtsF2htNAl4ITNrlcpGEex9yvj-DRsfFpQMOsN73zgt4FMWtIqcd_x3-R83_K5NSGe8jN-E3xck039E_F5GtrNT_ajMy7SwcfcZ3cX57fTq2z25_J6ejbLbA6oM61R2bJsKqNtozQStVhaC9aasqVCy8ZSYaDK26Zoq0bbtgSJUlSqgg6pyffZ8XvuOvjHgWKql3205JxZkR9ijVoJiWUuylEq36V2fDYG6up16JcmbGqE-pVjPXKs_-c42o4-LgzNktov0ye479xn7xKF-OCGZwr1goxLi7c8rXKZCUAFYtyysaXOXwDobn1f</recordid><startdate>20150201</startdate><enddate>20150201</enddate><creator>van Leeuwen, Michiel C. E.</creator><creator>van der Wal, Martijn B. A.</creator><creator>Bulstra, Anne-Eva J.</creator><creator>Galindo-Garre, Francisca</creator><creator>Molier, Jonneke</creator><creator>van Zuijlen, Paul P. M.</creator><creator>van Leeuwen, Paul A. M.</creator><creator>Niessen, Frank B.</creator><general>American Society of Plastic Surgeons</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20150201</creationdate><title>Intralesional Cryotherapy for Treatment of Keloid Scars: A Prospective Study</title><author>van Leeuwen, Michiel C. E. ; van der Wal, Martijn B. A. ; Bulstra, Anne-Eva J. ; Galindo-Garre, Francisca ; Molier, Jonneke ; van Zuijlen, Paul P. M. ; van Leeuwen, Paul A. M. ; Niessen, Frank B.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3016-6615c88b9a6cb561eed18cc0cca8de764bce7a093db7d9b6cd8041429590f1eb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Asian People</topic><topic>Black or African American</topic><topic>Black People</topic><topic>Child</topic><topic>Cryosurgery - adverse effects</topic><topic>Cryosurgery - instrumentation</topic><topic>Cryosurgery - methods</topic><topic>Female</topic><topic>Humans</topic><topic>Hypopigmentation - etiology</topic><topic>Injections, Intralesional</topic><topic>Keloid - complications</topic><topic>Keloid - therapy</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Needles</topic><topic>Netherlands</topic><topic>Nitrogen - administration &amp; dosage</topic><topic>Nitrogen - therapeutic use</topic><topic>Pain - etiology</topic><topic>Postoperative Complications - etiology</topic><topic>Prospective Studies</topic><topic>Pruritus - etiology</topic><topic>Recurrence</topic><topic>Severity of Illness Index</topic><topic>Skin Pigmentation</topic><topic>White People</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>van Leeuwen, Michiel C. E.</creatorcontrib><creatorcontrib>van der Wal, Martijn B. A.</creatorcontrib><creatorcontrib>Bulstra, Anne-Eva J.</creatorcontrib><creatorcontrib>Galindo-Garre, Francisca</creatorcontrib><creatorcontrib>Molier, Jonneke</creatorcontrib><creatorcontrib>van Zuijlen, Paul P. M.</creatorcontrib><creatorcontrib>van Leeuwen, Paul A. M.</creatorcontrib><creatorcontrib>Niessen, Frank B.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Plastic and reconstructive surgery (1963)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>van Leeuwen, Michiel C. E.</au><au>van der Wal, Martijn B. A.</au><au>Bulstra, Anne-Eva J.</au><au>Galindo-Garre, Francisca</au><au>Molier, Jonneke</au><au>van Zuijlen, Paul P. M.</au><au>van Leeuwen, Paul A. M.</au><au>Niessen, Frank B.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Intralesional Cryotherapy for Treatment of Keloid Scars: A Prospective Study</atitle><jtitle>Plastic and reconstructive surgery (1963)</jtitle><addtitle>Plast Reconstr Surg</addtitle><date>2015-02-01</date><risdate>2015</risdate><volume>135</volume><issue>2</issue><spage>580</spage><epage>589</epage><pages>580-589</pages><issn>0032-1052</issn><issn>1529-4242</issn><eissn>1529-4242</eissn><abstract>Intralesional cryotherapy is a novel treatment for keloid scars in which the scar is frozen from inside. Published results are promising, but the treatment has only been tested in a Caucasian patient population. Therefore, the authors evaluated intralesional cryotherapy in a patient population including different Fitzpatrick skin types (I through VI). This prospective multicenter study with a 1-year follow-up included 27 patients with 29 keloid scars. Intralesional cryotherapy was administered with a disposable liquid nitrogen-based device called CryoShape. Scar assessment was performed using the Patient and Observer Scar Assessment Scale and four objective devices to determine scar color, scar elasticity, scar volume, and patient skin type. Keloid scars showed an average volume decrease of 63 percent (range, 16 to 100 percent) after 12 months, compared with baseline (p &lt; 0.01). Recurrence was seen in seven keloids (24 percent) and hypopigmentation recovered in 69 percent of all keloid scars within 12 months. Scar assessment with the Patient and Observer Scar Assessment Scale showed an overall improvement according to both doctors and patients. In addition, complaints of pain and itching were reduced. When analyzing the results per Fitzpatrick skin type, African American patients showed a higher incidence of persistent hypopigmentation (p = 0.02). Intralesional cryotherapy for the treatment of keloid scars shows favorable results in terms of reduction of volume and complaints of pain and pruritus. However, no complete eradication was obtained in some cases and recurring scars were seen. In addition, persistent hypopigmentation proved a problem in non-Caucasian patients. Therapeutic, IV.</abstract><cop>United States</cop><pub>American Society of Plastic Surgeons</pub><pmid>25626801</pmid><doi>10.1097/PRS.0000000000000911</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0032-1052
ispartof Plastic and reconstructive surgery (1963), 2015-02, Vol.135 (2), p.580-589
issn 0032-1052
1529-4242
1529-4242
language eng
recordid cdi_proquest_miscellaneous_1652418328
source MEDLINE; Journals@Ovid Complete
subjects Adolescent
Adult
Aged
Asian People
Black or African American
Black People
Child
Cryosurgery - adverse effects
Cryosurgery - instrumentation
Cryosurgery - methods
Female
Humans
Hypopigmentation - etiology
Injections, Intralesional
Keloid - complications
Keloid - therapy
Male
Middle Aged
Needles
Netherlands
Nitrogen - administration & dosage
Nitrogen - therapeutic use
Pain - etiology
Postoperative Complications - etiology
Prospective Studies
Pruritus - etiology
Recurrence
Severity of Illness Index
Skin Pigmentation
White People
Young Adult
title Intralesional Cryotherapy for Treatment of Keloid Scars: A Prospective Study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T17%3A10%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Intralesional%20Cryotherapy%20for%20Treatment%20of%20Keloid%20Scars:%20A%20Prospective%20Study&rft.jtitle=Plastic%20and%20reconstructive%20surgery%20(1963)&rft.au=van%20Leeuwen,%20Michiel%20C.%20E.&rft.date=2015-02-01&rft.volume=135&rft.issue=2&rft.spage=580&rft.epage=589&rft.pages=580-589&rft.issn=0032-1052&rft.eissn=1529-4242&rft_id=info:doi/10.1097/PRS.0000000000000911&rft_dat=%3Cproquest_cross%3E1652418328%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1652418328&rft_id=info:pmid/25626801&rfr_iscdi=true